What are the latest updates on TPX-0046?
Designed to be Different.
TPX-0046 inhibits RET signaling in certain cancers. RET is a receptor tyrosine kinase, and constitutive activation of RET through mutations, amplifications and fusions have been found in multiple tumor types, including lung cancer, thyroid cancer and colon cancer.
